课题基金 / 基金详情

WT1 P53 INTERACTIONS IN IGF I RECEPTOR REGULATION

WT1 P53 INTERACTIONS IN IGF I RECEPTOR REGULATION
WT1 P53 在 IGF I 受体调节中的相互作用
批准号:
2736212
负责人:
Charles T Roberts
金额:
$2.0万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 2000-06-30

项目摘要

项目成果

Charles T Roberts的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION The IGF-I-R mediates the biological actions of the IGFs, and has been implicated in malignant transformation. The long-term objectives of this proposal are (1) to determine how p53 (a widely distributed nuclear protein which functions as a tumor suppressor by blocking progression of cells through the cell cycle by binding to components of basal transcription machinery) and WT1 (an organ-specific transcription factor which represses IGF-I-R expression by binding to specific sites in the IGF-I-R promoter) cooperate to repress IGF-I-R gene expression, and (2) to determine how mutations of either WT1 or p53 may disrupt the interactions between both proteins and/or between these proteins and the IGF-I-R promoter, resulting in deregulated expression of the receptor. Pilot studies suggest that p53 repression of IGF-I-R results from binding of p53 to TBP, presumably precluding the formation of a functional transcription initiation complex. The specific aims of the proposal are to demonstrate functional interaction between WT1 and p53, to analyze the WT1/p53 interaction on the IGF-I-R promoter in vitro, and to verify this interaction in the regulation of endogenous IGF-I-R.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
YR 50 PROJ- ROBERTS PRIMATE ISLET
MOLECULAR MECHANISMS OF HUMAN AND MURINE BETA CELL PROLIFERATION & REGENERATION
HERSTATIN: A NOVEL CANCER THERAPEUTIC
HERSTATIN: A NOVEL CANCER THERAPEUTIC